Prediction of treatment response to adalimumab: a double-blind placebo-controlled study of circulating microRNA in patients with early rheumatoid arthritis.

Sophine B. Krintel,Christian Dehlendorff,Merete Lund Hetland,Kim Hørslev-Petersen,Klaus Kaae Andersen,Peter Junker,Jan Pødenphant,Torkell Ellingsen,Palle Ahlquist,Hanne Merete Lindegaard,Asta Linauskas,Annette Schlemmer,Mette Yde Dam,I. Hansen,Hans Christian Horn,A Jørgensen,Johnny Lillelund Raun,Christian Gytz Ammitzbøll,Mikkel Østergaard,Kristian Stengaard–Pedersen,J.S. Johansen

Prediction of treatment response to adalimumab: a double-blind placebo-controlled study of circulating microRNA in patients with early rheumatoid arthritis.

2016

Prediction of treatment response to adalimumab: a double-blind placebo-controlled study of circulating microRNA in patients with early rheumatoid arthritis

Keywords:

Pharmacology
Rheumatoid arthritis
Oncology
Adalimumab
Circulating MicroRNA
Placebo-controlled study
Biology
Internal medicine
Immunology
treatment response
in patient
Gastroenterology
early rheumatoid arthritis
double blind

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations